StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.48−0.08 (-5.13%)

Close on Nov 17, 2026Market cap $526.23MP/E –Yield –

Evotec revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was €788.37M, down 1.1% from the year before. The highest annual figure on record is €796.97M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025€788.37M-1.1%
FY2024Dec 31, 2024€796.97M+2.0%
FY2023Dec 31, 2023€781.43M+4.0%
FY2022Dec 31, 2022€751.45M+21.6%
FY2021Dec 31, 2021€618.03M+23.4%
FY2020Dec 31, 2020€500.92M+12.2%
FY2019Dec 31, 2019€446.44M–

More Evotec figures

See a number that looks wrong?